Celiac disease

Celiac Disease, also known as celiac sprue or gluten-sensitive enteropathy, causes damage to the small intestine in response to gluten consumption. Below are COVID news and research updates that specifically relate to Celiac Disease.

Autoimmunity & COVID: Are You More at Risk?

Researchers in Italy studied whether autoimmunity increased the risk of SARS-CoV-2 infection in patients not taking immunosuppressive drugs. Researchers contacted 400 patients with the following autoimmune diseases: autoimmune gastritis, celiac disease, autoimmune thyroid disease (both Graves’ disease and Hashimoto’s thyroiditis), and Type 1 diabetes. Positive COVID-19 test results were reported in 33 patients. Only 3 of the 33 patients required hospitalization, while 8 were asymptomatic, and 22 had mild symptoms. No deaths were recorded.

Read More »

Covid-19 Outcomes in Autoimmune Disease Patients

Autoimmune disease is currently considered a risk factor for severe COVID-19. A research article published in Rheumatology last Fall summarized 30-day outcomes of autoimmune disease (AD) patients following hospitalization with COVID-19. AD patients diagnosed and/or hospitalized between January and June 2020 with COVID-19 were included, and their 30 day outcomes were compared to patients with at least one AD hospitalized with influenza from September 2017 through April 2018.

Read More »

Treating MIS-C with Phase 3 Celiac Drug

Even after a COVID-19 infection has passed, SARS-CoV-2 particles may linger in the gut and make their way into the bloodstream. This often triggers a cytokine storm and hyper-inflammatory response (MIS-C) within multiple areas of the body. These include the heart, lungs, kidneys, brain, and GI organs. 

Read More »
Join Our Community!Stay Informed. Stay Hopeful.

Sign up for periodic emails with resources, insights, and updates on autoimmune disease and living with chronic illness.

By adding your phone number, you agree to receive text message updates. Msg & data rates may apply.